ProfileGDS4718 / 226340_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 92% 90% 91% 90% 89% 88% 88% 91% 89% 91% 92% 87% 92% 89% 87% 87% 89% 88% 98% 88% 89% 88% 89% 90% 89% 91% 96% 92% 92% 84% 90% 92% 88% 89% 86% 90% 90% 90% 87% 88% 92% 91% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.8310793
GSM549102patient 115, normal, homogenized [OPG study]9.5551192
GSM549104patient 119, normal, homogenized [OPG study]9.2153490
GSM549108patient 138, normal, homogenized [OPG study]9.2956791
GSM549119patient 077, normal, homogenized [OPG study]9.2900890
GSM549133patient 032, cancer, homogenized [OPG study]9.2092489
GSM549139patient 042, cancer, homogenized [OPG study]8.8439888
GSM549099patient 107, normal, homogenized [OPG study]8.8345388
GSM549109patient 139, normal, homogenized [OPG study]9.3955891
GSM549110patient 046, normal, homogenized [OPG study]9.0743389
GSM549114patient 063, normal, homogenized [OPG study]9.5109391
GSM549122patient 082, normal, homogenized [OPG study]9.6664292
GSM549134patient 033, cancer, homogenized [OPG study]8.7653187
GSM549136patient 036, cancer, homogenized [OPG study]9.51292
GSM549140patient 044, cancer, homogenized [OPG study]9.142589
GSM549111patient 047, normal, homogenized [OPG study]8.8746387
GSM549113patient 057, normal, homogenized [OPG study]8.8438887
GSM549132patient 031, cancer, homogenized [OPG study]8.962289
GSM549137patient 038, cancer, homogenized [OPG study]8.8114188
GSM549142patient 047, cancer, homogenized [OPG study]11.085898
GSM549100patient 110, normal, homogenized [OPG study]8.7925188
GSM549107patient 135, normal, homogenized [OPG study]9.0512189
GSM549115patient 068, normal, homogenized [OPG study]9.0319988
GSM549116patient 072, normal, homogenized [OPG study]9.1315789
GSM549120patient 078, normal, homogenized [OPG study]9.2363890
GSM549131patient 030, cancer, homogenized [OPG study]9.1010589
GSM549118patient 074, normal, homogenized [OPG study]9.4010691
GSM549129patient 027, cancer, homogenized [OPG study]10.157596
GSM549123patient 088, normal, homogenized [OPG study]9.691392
GSM549124patient 006, cancer, homogenized [OPG study]9.3429292
GSM549126patient 015, cancer, homogenized [OPG study]8.348984
GSM549128patient 025, cancer, homogenized [OPG study]9.2190790
GSM549103patient 117, normal, homogenized [OPG study]9.5518792
GSM549117patient 073, normal, homogenized [OPG study]9.094288
GSM549138patient 041, cancer, homogenized [OPG study]9.1051489
GSM549141patient 045, cancer, homogenized [OPG study]8.680886
GSM549130patient 028, cancer, homogenized [OPG study]9.1420490
GSM549101patient 111, normal, homogenized [OPG study]9.2186490
GSM549105patient 128, normal, homogenized [OPG study]9.2199190
GSM549106patient 134, normal, homogenized [OPG study]8.9367787
GSM549112patient 048, normal, homogenized [OPG study]8.9279788
GSM549125patient 011, cancer, homogenized [OPG study]9.4344192
GSM549127patient 024, cancer, homogenized [OPG study]9.221891
GSM549135patient 035, cancer, homogenized [OPG study]9.1168589